Aktie A1J2Y5 PURE BIOSCIENCE, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen PURE Bioscience, Inc.

Aktien

A1J2Y5

US74621T2096

PURE

Verzögert OTC Markets
Andere Börsenplätze
 15:32:03 09.05.2024 		% 5 Tage % 1. Jan.
0.074 USD -12.84% Intraday Chart für PURE Bioscience, Inc. +5.71% -42.95%
06.05. PURE Bioscience ernennt Darin Zehr zum Vorstandsmitglied CI
18.03. PURE Bioscience, Inc. meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 31. Januar 2024 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
PURE Bioscience Appoints Darin Zehr to Board of Directors
PURE Bioscience Appoints Darin Zehr to Board of Directors
PURE Bioscience, Inc. announced that it has received $3 million in funding
PURE Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024
PURE Bioscience Reports Fiscal Second Quarter 2024 Financial Results
PURE Bioscience, Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023
PURE Bioscience Reports Fiscal First Quarter 2024 Financial Results
PURE Bioscience, Inc. Reports Earnings Results for the Full Year Ended July 31, 2023
PURE Bioscience Reports Fiscal 2023 Financial Results
PURE Bioscience to unveil “PURE Genius” Food Safety Program at the Annual International Association for Food Protection Meeting
PURE Bioscience, Inc. announced that it has received $1.8 million in funding
PURE Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023
PURE Bioscience Reports Fiscal 2023 Third Quarter And Nine-Month Financial Results
PURE BIOSCIENCE, INC. : Change in Directors or Principal Officers (form 8-K)
Pure Bioscience, Inc. Announces CEO Changes
Pure Bioscience, Inc. Announces Management Changes
PURE Bioscience Reports Fiscal 2023 Second Quarter And Six-Month Financial Results
PURE BIOSCIENCE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
PURE Bioscience Reports Fiscal 2023 Second Quarter And Six-Month Financial Results
PURE BIOSCIENCE, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A1J2Y5 Aktie
  4. Nachrichten PURE Bioscience, Inc.
  5. Andere Sprachen